DONADELLI, Massimo
 Distribuzione geografica
Continente #
NA - Nord America 3.261
EU - Europa 2.841
AS - Asia 976
SA - Sud America 12
OC - Oceania 6
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.099
Nazione #
US - Stati Uniti d'America 3.238
GB - Regno Unito 1.152
CN - Cina 771
IT - Italia 440
FR - Francia 269
SE - Svezia 264
IE - Irlanda 235
DE - Germania 177
FI - Finlandia 148
VN - Vietnam 82
UA - Ucraina 61
TR - Turchia 38
BE - Belgio 32
KR - Corea 27
CA - Canada 22
ES - Italia 15
IR - Iran 14
IN - India 13
NL - Olanda 13
RU - Federazione Russa 11
SG - Singapore 9
AU - Australia 6
JP - Giappone 5
SA - Arabia Saudita 5
BR - Brasile 4
PL - Polonia 4
CH - Svizzera 3
CL - Cile 3
ID - Indonesia 3
RO - Romania 3
BO - Bolivia 2
CO - Colombia 2
IL - Israele 2
MY - Malesia 2
NO - Norvegia 2
SK - Slovacchia (Repubblica Slovacca) 2
AL - Albania 1
BG - Bulgaria 1
BY - Bielorussia 1
EE - Estonia 1
EG - Egitto 1
EU - Europa 1
GR - Grecia 1
HK - Hong Kong 1
HR - Croazia 1
HU - Ungheria 1
IQ - Iraq 1
KG - Kirghizistan 1
KW - Kuwait 1
LU - Lussemburgo 1
MD - Moldavia 1
MX - Messico 1
NG - Nigeria 1
PE - Perù 1
PT - Portogallo 1
TH - Thailandia 1
Totale 7.099
Città #
Southend 1.082
Chandler 676
Jacksonville 360
Woodbridge 328
Ann Arbor 301
Dublin 233
Verona 191
Beijing 146
New York 146
Houston 141
Ashburn 138
Lawrence 93
Princeton 93
Wilmington 89
Nanjing 73
Jinan 70
Redmond 70
Shenyang 61
Hebei 48
Dong Ket 45
Helsinki 44
Phoenix 44
Tianjin 42
Redwood City 34
Changsha 33
Sindelfingen 33
Brussels 32
Haikou 30
Venice 30
Zhengzhou 29
Nanchang 28
Seoul 26
Düsseldorf 24
Ningbo 22
Norwalk 21
Jiaxing 20
Boardman 19
Hangzhou 19
Seattle 17
Taizhou 16
Guangzhou 13
Milan 13
Taiyuan 13
Caserta 12
Augusta 11
Washington 11
Toronto 10
Auburn Hills 9
Falls Church 9
Fuzhou 9
Madrid 9
San Francisco 8
Dearborn 7
Mestre 7
Ardabil 6
Lanzhou 6
San Mateo 6
Chions 5
Clearwater 5
Fairfield 5
Leawood 5
Monmouth Junction 5
Montréal 5
Mumbai 5
San Giovanni Ilarione 5
Cambridge 4
Chicago 4
Cleveland 4
Riyadh 4
San Diego 4
Boydton 3
Edinburgh 3
Elora 3
Groningen 3
Hanoi 3
Kemerovo 3
Lappeenranta 3
London 3
Los Angeles 3
Nürnberg 3
Poggio Rusco 3
Rome 3
San Jose 3
Singapore 3
Tokyo 3
Tombolo 3
Aarau 2
Amsterdam 2
Andover 2
Bologna 2
Bratislava 2
Caerano di San Marco 2
Canberra 2
Carate Brianza 2
Dongguan 2
Esslingen am Neckar 2
Frankfurt am Main 2
Henderson 2
Irving 2
Jakarta 2
Totale 5.242
Nome #
Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism 213
Gemcitabine response in pancreatic adenocarcinoma cells is synergistically enhanced by dithiocarbamate derivatives 156
Gene expression profiling after treatment with the histone deacetylase inhibitor trichostatin A reveals altered expression of both pro- and anti-apoptotic genes in pancreatic adenocarcinoma cells. 131
Expression of the antiapoptotic protein BAG3 is a feature of pancreatic adenocarcinoma and its overexpression is associated with poorer survival 129
ISOLATION AND DRUG SENSITIVITY OF CANCER STEM CELLS OBTAINED FROM PANCREATIC ADENOCARCINOMA CELL LINES 126
UCP2 inhibition triggers ROS-dependent nuclear translocation of GAPDH and autophagic cell death in pancreatic adenocarcinoma cells 122
Role of mitochondrial uncoupling protein-2 in cancer cell resistance to gemcitabine 121
Autophagy induced by p53-reactivating molecules protects pancreatic cancer cells from apoptosis. 116
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) 115
Activation of the Interleukin-6 promoter by a dominant negative mutant of c-Jun 113
REDOX SIGNALING HYPERSENSITIVITY DISTINGUISHES CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS WITH FAVORABLE PROGNOSIS 111
Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways 109
Mutant p53 proteins counteract autophagic mechanism sensitizing cancer cells to mTOR inhibition 107
Cytotoxicity of Polyspermine-Ribonuclease A and Polyspermine-Dimeric Ribonuclease A 106
Comparative proteomic and phosphoproteomic profiling of pancreatic adenocarcinoma cells treated with CB1 or CB2 agonists 104
HUMAN T-LYMPHOBLASTIC LEUKAEMIA CELLS PRODUCE IL-8 IN RESPONSE TOCXCL12 SECRETED BY NORMAL BONE MARROW STROMA 104
Regulation of miR-23b expression and its dual role on ROS production and tumour development 103
Cannabinoids inhibit energetic metabolism and induce AMPK-dependent autophagy in pancreatic cancer cells 100
Synergistic inhibition of pancreatic adenocarcinoma cell growth by trichostatin A and gemcitabine 99
Trichostatin A enhances the response of chemotherapeutic agents in inhibiting pancreatic cancer cell proliferation. 98
Hyaluronic acid-coated liposomes for active targeting of gemcitabine 96
Proteomics in pancreatic cancer research. 95
Pancreatic endocrine tumours, a proteomic investigation of the trichostatin-A antitumoral effect 95
Intracellular zinc increase inhibits p53(-/-) pancreatic adenocarcinoma cell growth by ROS/AIF-mediated apoptosis 94
Onconase induces autophagy sensitizing pancreatic cancer cells to gemcitabine and activates Akt/mTOR pathway in a ROS-dependent manner 94
Identification of a candidate alternative promoter region of the human Bcl2L11 (Bim) gene 93
CXCL12-MEDIATED NF-KAPPAB AND C-JUN ACTIVATION REGULATES INTERLEUKIN 8 PRODUCTION IN HUMAN T-LYMPHOBLASTIC LEUKEMIA 93
Biopsychosocial model of resilience in young adults with multiple sclerosis (BPS-ARMS): an observational study protocol exploring psychological reactions early after diagnosis 93
Antioxidant Mechanisms and ROS-Related MicroRNAs in Cancer Stem Cells 91
Bovine seminal ribonuclease triggers Beclin1-mediated autophagic cell death in pancreatic cancer cells 90
Increase of RNase A N-terminus Polarity or C-terminus Apolarity Changes the Two Domains' Propensity To Swap and Form the Two Dimeric Conformers of the Protein 89
Zinc depletion efficiently inhibits pancreatic cancer cell growth by increasing the ratio of antiproliferative/proliferative genes. 87
Growth delay of human pancreatic cancer cells by methylase inhibitor 5-aza-2'-deoxycytidine treatment is associated with activation of the interferon signalling pathway 84
Gain-of-function mutant p53 enhances mitochondrial ROS through the inhibition of PGC-1α/UCP2 axis in cancer cells 84
Proteomic analysis of pancreatic ductal carcinoma cells treated with 5-aza-2'-deoxycytidine 83
Double Domain Swapping in Bovine Seminal RNase: Formation of Distinct N- and C-swapped Tetramers and Multimers with Increasing Biological Activities 83
The antioxidant uncoupling protein 2 stimulates hnRNPA2/B1, GLUT1 and PKM2 expression and sensitizes pancreas cancer cells to glycolysis inhibition 83
MeCP2/H3meK9 are involved in IL-6 gene silencing in pancreatic adenocarcinoma cell lines 82
Mutant p53 stimulates chemoresistance of pancreatic adenocarcinoma cells to gemcitabine 79
Regulation of catalase expression in chronic lymphocytic leukemia cells. 78
UCP2, a mitochondrial protein regulated at multiple levels 76
Onconase Dimerization Through 3D Domain Swapping: Structural Investigations and Increase Of The Apoptotic Effect In Cancer Cells 76
The metabolic landscape of cancer stem cells 75
The antioxidant mitochondrial protein UCP2 promotes cancer development connecting theWarburg effect and autophagy 74
Proteomic analysis of pancreatic ductal carcinoma cells after combined treatment with gemcitabine and trichostatin A 73
Targeting gemcitabine containing liposomes to CD44 expressing pancreatic adenocarcinoma cells causes an increase in the antitumoral activity 73
UCP2 inhibition induces ROS/Akt/mTOR axis: role of GAPDH nuclear translocation in genipin/everolimus anticancer synergism 73
Mutant p53 and mTOR/PKM2 regulation in cancer cells 72
Targeting survival signaling pathways in chronic lymphocytic leukemia via anti-CD20 antibodies 72
“Proteomic profiling of pancreatic ductal carcinoma cell lines treated with trichostatin-A” 71
Low catalase expression confers redox hypersensitivity and identifies an indolent clinical behavior in CLL 70
Synergistic effect of trichostatin A and 5-aza-2'-deoxycytidine on growth inhibition of pancreatic endocrine tumour cell lines: a proteomic study. 69
Mutant p53 proteins alter cancer cell secretome and tumour microenvironment: involvement in cancer invasion and metastasis 69
Effects of CD20 antibodies and kinase inhibitors on B-cell receptor signalling and survival of chronic lymphocytic leukaemia cells 69
Mitochondrial uncoupling protein-2 inhibition promotes gemcitabine response in cancer cells. 68
Mutant p53 blocks SESN1/AMPK/PGC-1α/UCP2 axis increasing mitochondrial O2-· production in cancer cells 68
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 65
Mutant p53-Associated Molecular Mechanisms of ROS Regulation in Cancer Cells 64
Proteomic analysis of pancreatic endocrine tumor cell lines treated with the histone deacetylase inhibitor trichostatin A. 63
Mitochondrial uncoupling protein 2 and pancreatic cancer: a new potential target therapy 63
A comparison study on RNase A oligomerization induced by cisplatin, carboplatin and oxaliplatin 63
Molecular interplay between mutant p53 proteins and autophagy in cancer cells 62
Oncometabolites in cancer aggressiveness and tumour repopulation 62
Rehabilitation and biomarkers of stroke recovery: study protocol for a randomized controlled trial 61
Trichostatin A alters cytoskeleton and energy metabolism of pancreatic adenocarcinoma cells: an in depth proteomic study 60
Browsing the oldest antioxidant enzyme: catalase and its multiple regulation in cancer 60
Cell communication and signaling: how to turn bad language into positive one 59
Regulation of autophagy by nuclear GAPDH and its aggregates in cancer and neurodegenerative disorders 57
Autocrine mechanisms of cancer chemoresistance 55
Extracellular matrix composition modulates the responsiveness of differentiated and stem pancreatic cancer cells to lipophilic derivate of gemcitabine 54
The rs1001179 SNP and CpG methylation regulate catalase expression in chronic lymphocytic leukemia 52
The cancer secretome and secreted biomarkers 52
Mutant p53 induces SIRT3/MnSOD axis to moderate ROS production in melanoma cells 51
Roles for microRNA 23b in regulating autophagy and development of pancreatic adenocarcinoma 49
ABCA1/ABCB1 Ratio Determines Chemo- and Immune-Sensitivity in Human Osteosarcoma 49
Sestrins at the Interface of ROS Control and Autophagy Regulation in Health and Disease 48
Interplay between ROS and Autophagy in Cancer and Aging: From Molecular Mechanisms to Novel Therapeutic Approaches 46
Tumor Suppressor Role of Wild-Type P53-Dependent Secretome and Its Proteomic Identification in PDAC 46
The mutant p53-driven secretome has oncogenic functions in pancreatic ductal adenocarcinoma cells 45
Proteomic Signature of PDAC Cells with Mutant p53 44
Gut microbiota modulates seizure susceptibility 42
Mutant p53 prevents GAPDH nuclear translocation in pancreatic cancer cells favoring glycolysis and 2-deoxyglucose sensitivity 40
Reprogramming tumor-immune cell interface in solid and hematological malignancies to enhance response to therapy 38
MRP5 nitration by NO-releasing gemcitabine encapsulated in liposomes confers sensitivity in chemoresistant pancreatic adenocarcinoma cells 38
Redox sensitive cysteine residues as crucial regulators of wild-type and mutant p53 isoforms 38
Prolonged exposure to simulated microgravity promotes stemness impairing morphological, metabolic and migratory profile of pancreatic cancer cells: a comprehensive proteomic, lipidomic and transcriptomic analysis 38
Regulation of succinate dehydrogenase and role of succinate in cancer 37
Sestrins as a therapeutic bridge between ROS and autophagy in cancer 36
From single gene analysis to single cell profiling: a new era for precision medicine 34
3-Bromo-Isoxazoline Derivatives Inhibit GAPDH Enzyme in PDAC Cells Triggering Autophagy and Apoptotic Cell Death 33
Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer 30
miR-125b Upregulates miR-34a and Sequentially Activates Stress Adaption and Cell Death Mechanisms in Multiple Myeloma 30
Hypoxia dictates metabolic rewiring of tumors: implications for chemoresistance 29
Hypoxia, endoplasmic reticulum stress and chemoresistance: dangerous liaisons 28
Mitochondrial metabolic alterations in cancer cells and related therapeutic targets 27
Discovery of a spirocyclic 3-bromo-4,5-dihydroisoxazole covalent inhibitor of hGAPDH with antiproliferative activity against pancreatic cancer cells 16
To metabolomics and beyond: a technological portfolio to investigate cancer metabolism 15
Trichostatin A, an inhibitor of histone deacetylases, strongly suppresses growth of pancreatic adenocarcinoma cells 13
Increased stability of P21(WAF1/CIP1) mRNA is required for ROS/ERK-dependent pancreatic adenocarcinoma cell growth inhibition by pyrrolidine dithiocarbamate 12
B-cell receptor signaling activity identifies patients with mantle cell lymphoma at higher risk of progression 11
Totale 7.212
Categoria #
all - tutte 22.492
article - articoli 20.548
book - libri 0
conference - conferenze 1.944
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.984


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201982 0 0 0 0 0 0 0 0 0 0 43 39
2019/2020790 89 23 27 46 99 95 87 46 58 93 41 86
2020/2021893 130 105 40 79 103 90 33 49 45 10 106 103
2021/2022815 114 200 20 53 21 19 26 52 25 29 71 185
2022/20231.867 121 196 154 364 158 418 23 98 206 61 50 18
2023/2024762 37 56 74 92 116 217 29 78 15 48 0 0
Totale 7.235